NCT05495776 Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer
| NCT ID | NCT05495776 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State Scientific Centre of Coloproctology, Russian Federation |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2022-08-01 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective multicenter registry study to assess the frequency of Lynch syndrome among patients with colorectal cancer in Russia
Eligibility Criteria
Inclusion Criteria: * Provision of written informed consent; * Patients with histologically verified colon adenocarcinoma or patients with histologically verified synchronous neoplasms who have not previously received treatment for a second tumor; * Age ≥ 18 years; * Absence of antitumor treatment for a real tumor (it is allowed to include patients who have a history of antitumor treatment for other malignant tumors, if the period after treatment is more than 12 months). * The ability of the patient, according to the Researcher, to fulfill the requirements of the Protocol; Exclusion Criteria: \- Patients receiving chemotherapy or radiotherapy for colon cancer at the time of screening
Contact & Investigator
Alexey Tsukanov, PhD
PRINCIPAL INVESTIGATOR
Head of the Department of Laboratory Genetics
Frequently Asked Questions
Who can join the NCT05495776 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05495776 currently recruiting?
Yes, NCT05495776 is actively recruiting participants. Contact the research team at dr.semenov@inbox.ru for enrollment information.
Where is the NCT05495776 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT05495776 clinical trial?
NCT05495776 is sponsored by State Scientific Centre of Coloproctology, Russian Federation. The principal investigator is Alexey Tsukanov, PhD at Head of the Department of Laboratory Genetics. The trial plans to enroll 2,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.